PnuVax

Kingston, Ontario Canada

Medical / Health Care / Pharmaceuticals

PnuVax is an international biopharmaceutical and vaccine company that operates under the direction of former Celltrion president and current Chinese Academy of Sciences industrial biotechnology professor Donald F. Gerson. A privately held medical immunization developer and manufacturer since 2009, PnuVax combats established and emerging infectious diseases on multiple continents from its headquarters in the Canadian city of Kingston, Ontario. The company also supports satellite offices in Montreal, Quebec. Key products developed or acquired by PnuVax include a multiple serotype vaccine for pneumonia and an inactivated cell-culture-based vaccine for yellow fever.